WASHINGTON — A top U.S. health official on Thursday called on lawmakers in Congress to do more to help bring down drug prices, saying that the Trump administration had “given them a lot of opportunities to step in here.”

“I think Congress can do more,” said Joe Grogan, associate director for health programs at the Office of Management and Budget. He added: “As we get to the sprint before the end of the year, there are a few things that they may take up, and we’re actively in discussions about that.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This is pure stagecraft or propaganda. It is like asking the fox to guard the hen house. The only thing for sure is that Congress will continue to ensure the profits of pharma, even as Americans die. Pharma gets what it pays for.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy